Lowry Caudill, PhD

Lowry is the former worldwide President of Pharmaceutical Development for Cardinal Health (NYSE:CAH). In April 2002, Cardinal Health acquired Magellan Laboratories, a pharmaceutical development company that Dr. Caudill and Dr. Alfred Childers co-founded in 1991. Under their leadership Magellan grew to 600 people with 500 employees in RTP and 100 employees in San Diego.

Magellan was recognized as one of the fastest growing, privately held companies in the Research Triangle area and received numerous regional and national awards for growth and entrepreneurial development. Magellan was awarded the Triangle Business Journal's Fast 50 award for nine years and was in the Top 10 for six of the nine years. In 1998, Drs. Caudill and Childers were named Entrepreneur of the Year for North and South Caroli na by Ernst and Young, The Kauffman Foundation, USA Today, and NASDAQ and were Finalists for the 1998 National Entrepreneur of The Year. More recently, they received two awards from the North Carolina Council for Entrepreneurial Development (CED), the 2002 Entrepreneurial Excellence Award and the 2002 Deal of the Year Award.

In 1987, he joined the Glaxo Research Institute where he played a major role in the establishment of the Analytical Chemistry Department in RTP.

Dr. Caudill is a Steering Committee member of the $1.8 billion Carolina First Campaign and is chair of the Private Fundraising Steering Committee for the UNC-CH Physical Science Complex. He is an Adjunct Professor of Chemistry at the University of North Carolina at Chapel Hill, a member of the University of North Carolina at Chapel Hill Chemistry Department External Advisory Board, an active member of the American Chemical Society (ACS) and the American Association of Pharmaceutical Scientists (AAPS). Dr. Caudill received his B.S. degree in Chemistry at the University of North Carolina at Chapel Hill and in 1983, he received his doctorate in Analytical Chemistry from Indiana University.